Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04551950
Title Bintrafusp Alfa Combination Therapy in Participants With Cervical Cancer (INTRAPID 046)
Recruitment Active, not recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors EMD Serono Research & Development Institute, Inc.
Indications

cervical adenocarcinoma

cervical adenosquamous carcinoma

cervical squamous cell carcinoma

Therapies

Bevacizumab + Carboplatin + M7824 + Paclitaxel

Bevacizumab + Cisplatin + M7824 + Paclitaxel

Cisplatin + M7824 + Paclitaxel

Cisplatin + M7824

Carboplatin + M7824 + Paclitaxel

Age Groups: adult | senior
Covered Countries USA | ESP


No variant requirements are available.